SIBN
Price
$23.75Alerts
Change
+$0.21 (+0.89%)
Updated
Nov 19 closing price
Capitalization
1.09B
102 days until earnings call
Intraday BUY SELL Signals
TCMD
Price
$25.99Alerts
Change
-$0.43 (-1.63%)
Updated
Nov 19 closing price
Capitalization
589.64M
96 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SIBN vs TCMD

SIBN vs TCMD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SIBN vs. TCMD commentary
Nov 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SIBN is a Hold and TCMD is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for SIBN with price predictions
Nov 19, 2026

SIBN in downward trend: price expected to drop as it breaks its higher Bollinger Band on November 03, 2026

SIBN broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 41 similar instances where the stock broke above the upper band. In 37 of the 41 cases the stock fell afterwards. This puts the odds of success at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SIBN moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 24 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 89%.

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SIBN as a result. In 65 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.

The Moving Average Convergence Divergence Histogram (MACD) for SIBN turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 39 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIBN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +2.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where SIBN advanced for three days, in 210 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

The Aroon Indicator entered an Uptrend today. In 135 of 194 cases where SIBN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.958) is normal, around the industry mean (4.142). P/E Ratio (-73.455) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.801) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. SIBN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIBN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for TCMD with price predictions
Nov 19, 2026

TCMD in upward trend: 10-day moving average moved above 50-day moving average on October 22, 2026

The 10-day moving average for TCMD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

TCMD moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where TCMD advanced for three days, in 211 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

The Aroon Indicator entered an Uptrend today. In 210 of 234 cases where TCMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for TCMD moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 30 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 62 cases where TCMD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 58%.

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TCMD as a result. In 74 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The Moving Average Convergence Divergence Histogram (MACD) for TCMD turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 29 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TCMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

TCMD broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. TCMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.634) is normal, around the industry mean (4.142). P/E Ratio (23.881) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.290) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.458) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TCMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
SIBN vs TCMD: Fundamental Ratings
SIBN
TCMD
OUTLOOK RATING
1..100
8990
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
68
Overvalued
PROFIT vs RISK RATING
1..100
91100
SMR RATING
1..100
9365
PRICE GROWTH RATING
1..100
3640
P/E GROWTH RATING
1..100
8777
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIBN's Valuation (8) in the Medical Specialties industry is somewhat better than the same rating for TCMD (68). This means that SIBN’s stock grew somewhat faster than TCMD’s over the last 12 months.

SIBN's Profit vs Risk Rating (91) in the Medical Specialties industry is in the same range as TCMD (100). This means that SIBN’s stock grew similarly to TCMD’s over the last 12 months.

TCMD's SMR Rating (65) in the Medical Specialties industry is in the same range as SIBN (93). This means that TCMD’s stock grew similarly to SIBN’s over the last 12 months.

SIBN's Price Growth Rating (36) in the Medical Specialties industry is in the same range as TCMD (40). This means that SIBN’s stock grew similarly to TCMD’s over the last 12 months.

TCMD's P/E Growth Rating (77) in the Medical Specialties industry is in the same range as SIBN (87). This means that TCMD’s stock grew similarly to SIBN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SIBNTCMD
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
58%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
75%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
57%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
62%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 20, 2026
Stock price -- (SIBN: $23.54 vs. TCMD: $26.42)
Brand notoriety: SIBN and TCMD are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: SIBN: 200% vs. TCMD: 89%
Market capitalization -- SIBN: $1.09B vs. TCMD: $589.64M
SIBN [@Medical/Nursing Services] is valued at $1.09B. TCMD’s [@Medical/Nursing Services] market capitalization is $589.64M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SIBN’s FA Score shows that 1 FA rating(s) are green while TCMD’s FA Score has 0 green FA rating(s).

  • SIBN’s FA Score: 1 green, 4 red.
  • TCMD’s FA Score: 0 green, 5 red.
According to our system of comparison, SIBN is a better buy in the long-term than TCMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SIBN’s TA Score shows that 2 TA indicator(s) are bullish while TCMD’s TA Score has 4 bullish TA indicator(s).

  • SIBN’s TA Score: 2 bullish, 6 bearish.
  • TCMD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TCMD is a better buy in the short-term than SIBN.

Price Growth

SIBN (@Medical/Nursing Services) experienced а -5.61% price change this week, while TCMD (@Medical/Nursing Services) price change was -2.62% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -9.30%. For the same industry, the average monthly price growth was -12.27%, and the average quarterly price growth was -15.98%.

Reported Earning Dates

SIBN is expected to report earnings on Mar 01, 2027.

TCMD is expected to report earnings on Feb 23, 2027.

Industries' Descriptions

@Medical/Nursing Services (-9.30% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

SIBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with ATEC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then ATEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
+0.89%
ATEC - SIBN
52%
Loosely correlated
-2.27%
OFIX - SIBN
46%
Loosely correlated
-4.08%
EW - SIBN
46%
Loosely correlated
-1.28%
MDT - SIBN
45%
Loosely correlated
-0.11%
SYK - SIBN
41%
Loosely correlated
-1.59%
More

TCMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCMD has been loosely correlated with CSTL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TCMD jumps, then CSTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCMD
1D Price
Change %
TCMD100%
-1.63%
CSTL - TCMD
50%
Loosely correlated
+0.07%
UFPT - TCMD
46%
Loosely correlated
-2.20%
IRMD - TCMD
43%
Loosely correlated
-1.28%
AORT - TCMD
43%
Loosely correlated
-0.05%
SIBN - TCMD
39%
Loosely correlated
+0.89%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMDB18.650.09
+0.48%
Costamare Bulkers Holdings Ltd
NTIC7.530.01
+0.13%
Northern Technologies International Corp
GLPI37.90-0.53
-1.38%
Gaming and Leisure Properties
BKE41.78-0.96
-2.25%
Buckle (The)
JEM2.46-0.24
-8.89%
707 Cayman Holdings Limited